PHARMACEUTICAL COMPOSITION FOR TREATING SPINOCEREBELLAR ATAXIA

CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Enhancing Oligonucleotide Immunomodulatory Activity through Dianophore Long-Lasting Modification: Methods and Applications

COMPOSITIONS AND METHODS FOR PROGRAMMED DEATH LIGAND RECEPTOR (PD-L1) EXPRESSION

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

PLIN1 RNAi INTERFERENCE AGENTS

COMPOSITIONS AND METHODS FOR DELIVERING A MACROMOLECULE TO A CELL

USE OF MIR-15A-5P IN TREATMENT OF FUNDUS OCULI DISEASE

MODIFIED RNA FOR INCREASING PROTEIN EXPRESSION

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

C-MYC-TARGETING CHARGE-ALTERING RELEASABLE TRANSPORTERS AS ANTI-TUMOR AGENTS FOR BREAST CANCER THERAPY

DNA-RNA HETERODUPLEX TARGETING ANDROGEN RECEPTOR

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

Methods for Directing Lipid Nanoparticles in Vivo

Use of a Janus Kinase Inhibitor and a Telomerase Inhibitor for the Treatment of Myeloproliferative Neoplasms

NUCLEIC ACID CARRIER AND METHOD FOR ADMINISTERING NUCLEIC ACID

OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE

EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A DUAL CLEAVABLE LINKER

REGULATION OF ACTIVITY OF RNAI MOLECULES

Synthetic Nanostructures Including Nucleic Acids and/or Other Entities

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

BRANCHED LIPID CONJUGATES OF siRNA FOR SPECIFIC TISSUE DELIVERY

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

RNA INTERFERENCE OLIGONUCLEOTIDES FOR INHIBITING PERINEURONAL NETWORK FORMATION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

Ligand-Modified Oligonucleotides

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

MODIFIED NUCLEIC ACID CONJUGATES

SIRNA MOLECULE AGAINST HUMAN TENASCIN-C (TNC) AND A PHARMACEUTICAL COMPOSITION COMPRISING IT

Conjugated Antisense Compounds and Their Use

17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

BBB-CROSSING LIPID LIGAND OF HETERO NUCLEIC ACID

TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS

Conjugated Antisense Compounds for Use in Therapy

APTAMER-BASED POLLUTANT PROTECTION

MUCIN-5B (MUC5B) TARGETED SIRNA AND ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF

CONJUGATES FOR TISSUE-SPECIFIC OLIGONUCLEOTIDE DELIVERY

SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY

HIGH-AFFINITY THROMBIN APTAMERS AND METHODS OF USE

TREATMENT OF CARDIOVASCULAR DISEASE

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

CERTAIN DUX4 INHIBITORS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF

Biradial Spherical Nucleic Acids

ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDES

OLIGONUCLEOTIDES FOR PRNP MODULATION

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ANTI-CANCER AGENTS

MSI2 AS A THERAPEUTIC TARGET FOR THE TREATMENT OF MYOTONIC DYSTROPHY

Ribonucleic Acids With 4'-Thio-Modified Nucleotides and Related Methods

XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DOUBLE-STRANDED RNA MOLECULE FOR ADMINISTRATION TO THE EYE

MODIFIED OLIGONUCLEOTIDES

OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES

OVERSUBSCRIPTION SCHEDULING

Targeting Ligands For Therapeutic Compounds

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO CNS TISSUE

IMMUNOSTIMULATORY COMPOSITIONS

BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF ALPHA-1 ANTITRYPSIN

RNAi Agents of Modulating PLP1

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

NONCOVALENTLY BRANCHED OLIGONUCLEOTIDE COMPOSITIONS

FULLY STABILIZED ASYMMETRIC SIRNA

LIPOPHILIC OLIGONUCLEOTIDE CONJUGATES

TARGETED COMPOSITIONS

COMPOUNDS AND METHODS FOR MODULATING SMN2

ACTIVE TARGETING MICRORNA OLIGONUCLEOTIDE THERAPEUTICS FOR THE TREATMENT OF CARDIO-METABOLIC DISEASES

APTAMERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR PREVENTING OR TREATING BCMA-ASSOCIATED DISEASES OR CONDITIONS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

Microtubule Associated Protein Tau (MAPT) iRNA Agent Compositions and Methods of Use Thereof

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

ANTI-PTEN RNA INTERFERENCE OLIGONUCLEOTIDES AND USES THEREOF

COMPOSITIONS CONTAINING POLYNUCLEOTIDE AMPHIPHILES AND METHODS OF USE THEREOF

RNAi OLIGONUCLEOTIDE CONJUGATES

TETRAMOLECULAR PARALLEL G-QUADRUPLEX-FORMING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES

DNA ORIGAMI STRUCTURE AND PROTEIN NANOPORE CONSTRUCT

CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING

COMPOSITIONS AND METHODS FOR SILENCING CARBONIC ANHYDRASE 2 EXPRESSION

HEPARIN SULFATE BIOSYNTHESIS PATHWAY ENZYME IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

DEGRADABLE LIPID COMPOUND FOR ACTIVE MOLECULE DELIVERY AND NANOCOMPLEX THEREOF

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

SGLT-2 TARGETING OLIGONUCLEOTIDES

TUNABLE REVERSIR TM COMPOUNDS

BIOACTIVE CONJUGATES FOR OLIGONUCLEOTIDE DELIVERY

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE (HMGCR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDES FOR SNCA MODULATION

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

LIPID-PEGYLATED COMPOUNDS, PREPARATIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

LIPID-BASED CONJUGATES FOR SYSTEMIC, CENTRAL NERVOUS SYSTEM, PERIPHERAL NERVOUS SYSTEM, AND OCULAR DELIVERY

AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS

HUNTINGTIN (HTT) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME

NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF

OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATION

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

OLIGONUCLEOTIDES FOR TISSUE SPECIFIC GENE EXPRESSION MODULATION

iRNA Compositions and Methods for Targeting ANGPTL7

CONDITION-ACTIVATABLE NUCLEIC ACID CONSTRUCTS AND THEIR USES FOR TREATING NEUROLOGICAL DISEASES

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

COMPOSITIONS AND METHODS FOR MODULATING PNPLA3 EXPRESSION

TUMOR DELIVERY OF DENDRITIC OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION

MICRORNA-29 COMPOUNDS, COMPOSITIONS AND USES IN THERAPY

OLIGOMERIC COMPOUND FOR DYSTROPHIN RESCUE IN DMD PATIENTS THROUGHOUT SKIPPING OF EXON-51

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

EXTRAHEPATIC DELIVERY

ANTISENSE INHIBITORS OF MIR17HG PRE-RNA AS THERAPEUTIC AGENTS IN CANCER

Compositions and methods for modulating apolipoprotein (a) expression

BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DNAZYMES TARGETING CELL WALL SYNTHESIS ENZYMES AND USES THEREOF

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SERUM AMYLOID A GENE

Double-Stranded Nucleic Acid Molecule for Treating Proliferative Vitreoretinopathy and Use Thereof

DISE-INDUCING SRNA-POLYPLEXES AND SRNA-LIPOPOLYPLEXES AND METHODS OF USING THE SAME TO TREAT CANCER

VON WILLEBRAND FACTOR (VWF)-TARGETING AGENTS AND METHODS OF USING THE SAME

Compositions and Methods for Silencing MYOC Expression

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

CHEMICALLY MODIFIED OLIGONUCLEOTIDES

LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

iRNA Compositions and Methods for Silencing Filamin A (FLNA)

NEW CONJUGATED NUCLEIC ACID MOLECULES AND THEIR USES

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ATXN2 IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING ATXN2-ASSOCIATED NEURODEGENERATIVE DISEASES

BRANCHED OLIGONUCLEOTIDES

TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS

OLIGONUCLEOTIDES FOR IFN-GAMMA SIGNALING PATHWAY MODULATION

LIPID CONJUGATION FOR TARGETING NEURONS OF THE CENTRAL NERVOUS SYSTEM

IL-15 Conjugates and Uses Thereof

Conjugated antisense compounds and their use

SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MIRNA INHIBITORS FOR PREVENTING AND TREATING ANEURYSMS, HYPERTENSION, ARDS AND OTHER DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION

LIPOPHILIC SIRNA CONJUGATES FOR THE TREATMENT OF INFLAMMATORY DISEASES

SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT

COMPOSITIONS AND METHODS FOR SILENCING CARBONIC ANHYDRASE 2 EXPRESSION

SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION FACTOR 6 (STAT6) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6

FATTY ACID CONJUGATES OF NUCLEIC ACIDS

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Compositions for Inhibiting Growth of Targeted Cells

MODULATING APOLIPOPROTEIN (A) EXPRESSION

iRNA COMPOSITIONS AND METHODS FOR SILENCING CHITINASE 3-LIKE PROTEIN 1/YKL-40 (CHI3L1/YKL-40) PROTEIN

ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 1 (ELOVL1) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE

STEAROYL-COA DESATURASE 5 (SCD5) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

OLIGONUCLEOTIDES TARGETING S6K1

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Non-liposomal systems for nucleic acid delivery

DOUBLE-STRANDED SIRNA HAVING PATTERNED CHEMICAL MODIFICATIONS

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

Skeletal Muscle Delivery Platforms and Methods of Use

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING

Conjugated Antisense Compounds for Use in Therapy

CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME

PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

GLYCOGEN SYNTHASE KINASE 3 ALPHA (GSK3 ALPHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

PRION PROTEIN (PRNP) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Lipid-pegylated compounds, preparations and uses thereof

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM

iRNA COMPOSITIONS AND METHODS FOR SILENCING AMYLOID PRECURSOR PROTEIN (APP)

MODIFIED HETERO NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

SUBSTANCES AND METHODS FOR TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

RNAi AGENT TARGETING MYD88 AND USE THEREOF

ANTISENSE OLIGOMERS TARGETING PCSK9

CONJUGATED OLIGONUCLEOTIDES

DIPEPTIDYL PEPTIDASE 4 (DPP4) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Lipids and compositions for the delivery of therapeutics

Oligomers and oligomer conjugates

RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use

GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY

Extrahepatic delivery

TREATMENT OF FUCHS' ENDOTHELIAL CORNEAL DYSTROPHY

COMPOSITIONS AND METHODS FOR INHIBITING SNCA EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING MAPT EXPRESSION

EXOSOMAL LOADING USING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES

G PROTEIN-COUPLED RECEPTOR 75 (GPR75) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

COMPOUNDS AND METHODS FOR MODULATING PMP22

Effect of Fuel Doping in ICF Targets

OLIGONUCLEIC ACID CONJUGATE

ENDOSOMAL ESCAPE DOMAINS FOR DELIVERY OF MACROMOLECULES INTO CELLS

METHODS AND COMPOSITIONS FOR MACROPHAGE POLARIZATION

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION

TREATMENT OF SKIN DISEASES AND DISORDERS USING INHIBITORS OF KALLIKREIN-RELATED PEPTIDASES (KLK)

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

Amphiregulin gene-specific double-stranded oligonucleotide and composition for preventing and treating fibrosis-related diseases and respiratory diseases, comprising same

IRNA COMPOSITIONS AND METHODS FOR SILENCING GROWTH FACTOR RECEPTOR BOUND PROTEIN 10 (GRB10) OR GROWTH FACTOR RECEPTOR BOUND PROTEIN 14 (GRB14) IN THE LIVER

ANTISENSE RNA FOR TREATMENT OF SARS-ASSOCIATED CORONAVIRUS

Modified oligonucleotides

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR

COMPOSITIONS AND METHODS FOR SILENCING MYOC EXPRESSION

METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS

Inhibition of lncExACT1 to Treat Heart Disease

RNAi COMPOSITIONS AND METHODS OF USE THEREOF FOR DELIVERY BY INHALATION

MUCOPENETRATING FORMULATIONS

siRNAs WITH VINYLPHOSPHONATE AT THE 5' END OF THE ANTISENSE STRAND

COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING COMPLEMENT COMPONENT C3-ASSOCIATED DISEASES

METHODS OF TREATING AND PREVENTING BACTERIAL INFECTIONS

Compositions and methods for inhibiting expression of transthyretin

APTAMER FOR IL-21 AND USE THEREOF

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA

MONOCYTE-SPECIFIC APTAMERS AND USES THEREOF FOR ENHANCING DRUG DELIVERY TO CANCER

SINGLE-STRANDED OLIGONUCLEOTIDE

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

Compositions and methods of treating muscle atrophy and myotonic dystrophy

Compositions and methods of treating muscle atrophy and myotonic dystrophy

CYTOTOXIC T-LYMPHOCYTE BINDING APTAMERS

BISPECIFIC PERSONALIZED APTAMERS

TRANSMEMBRANE SERINE PROTEASE 2 (TMPRSS2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

APOLIPOPROTEIN E (APOE) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Ribonucleic acids with 4′-thio-modified nucleotides and related methods

Immunostimulatory compositions

HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID

Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy

COMPOSITIONS AND METHODS FOR SILENCING SCN9A EXPRESSION

ANTISENSE OLIGONUCLEOTIDE OF CALM2

COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION MOTIF

COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION

OXIDIZED TUMOR CELL LYSATES ENCAPSULATED IN LIPOSOMAL SPHERICAL NUCLEIC ACIDS AS POTENT CANCER IMMUNOTHERAPEUTICS

SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

ALPHA-2A ADRENERGIC RECEPTOR (ADRA2A) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR SILENCING VEGF-A EXPRESSION

ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES

LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

USP10 TARGETED SELF-DELIVERABLE SIRNA COMPOSITIONS AND METHODS FOR PREVENTING OR INHIBITING FIBROSIS AND/OR SCARRING

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Targeted compositions

Nucleic acid and other compositions and methods for the modulation of cell membranes

CONDITIONAL-siRNAS AND USES THEREOF IN TREATING CARDIAC HYPERTROPHY

MICRORNA COMPOSITIONS AND METHODS OF USE

ANTI-ADAM33 OLIGONUCLEOTIDES AND RELATED METHODS

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

PRODUCTS AND COMPOSITIONS

MIR-149-3P AND METHOD FOR TREATING METABOLIC DISEASE USING THE SAME

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

4′-phosphate analogs and oligonucleotides comprising the same

ATAXIN3 (ATXN3) RNAI AGENT COMPOSITIONS AND METHODS OF USE THEREOF

METHOD AND COMPOSITION FOR MEASUREMENT OF NITRIC OXIDE

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent

SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Tunable Reversir™ compounds

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

Oligonucleotides for SARS-CoV-2 modulation

RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin

CHEMICALLY MODIFIED OLIGONUCLEOTIDES TARGETING BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) FOR IMMUNOTHERAPY

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODIFIED iRNA AGENTS

OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

ASYMMETRIC SIRNA INHIBITING EXPRESSION OF PD-1

Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof

HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

PPM1A INHIBITORS AND METHODS OF USING SAME

Dynamic pharmacokinetic-modifying anchors

Compositions and methods for modulating PNPLA3 expression

ANTISENSE OLIGONUCLEOTIDE CAPABLE OF ALTERING SPLICING OF DUX4 pre-mRNA